Application of Nanostructured Lipid Carriers in Antibacterial and Anticancer
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 103
Special Issue Editor
Interests: nanocolloidal systems for bioactive sustained delivery; nanoformulation characterization; nanotoxicity and efficacy assays
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanostructured lipid carriers (NLC) represent a significant advancement in drug delivery systems, offering improved bioavailability, stability, and the targeted delivery of therapeutic agents. Pharmaceutics is proud to present a Special Issue focused on the innovative applications of NLC as antibacterial and anticancer treatment candidates. This issue aims to explore the potential of NLC in enhancing the efficacy, stability, and targeted delivery of therapeutic agents. The scope encompasses the design, development, and clinical evaluation of NLC-based formulations, highlighting their role in overcoming drug resistance and minimizing side effects in both antibacterial and anticancer treatments. By consolidating cutting-edge research and reviews, this Special Issue seeks to provide a comprehensive understanding of the mechanisms and benefits of NLC, fostering advancements in pharmaceutical sciences. We invite researchers and practitioners to contribute their original research articles or reviews to drive innovation and improve patient outcomes in antibacterial and anticancer therapies.
Dr. Lígia N.M. Ribeiro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanostructured lipid carriers
- antibacterial therapy
- anticancer therapy
- drug delivery
- pharmaceutical nanotechnology
- targeted delivery
- drug resistance
- clinical evaluation
